Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants | View Drug Tariff history
| Description | Co-amoxiclav 250mg/62mg/5ml oral suspension 100 ml |
| BNF code | 0501013K0AAAIAI |
| Virtual Medicinal Product | Co-amoxiclav 250mg/62mg/5ml oral suspension |
| Quantity value | 100.00 |
| Quantity unit of measure | ml |
| Drug Tariff Category Information | |
|---|---|
| Drug Tariff payment category | Part VIIIA Category C |
| Drug Tariff price (pence) | 360 |
| Date from which applicable | 1 Oct 2024 |
| Previous price (pence) | 0 |
| Actual Medicinal Product Packs | |
| Augmentin 250/62 oral suspension (GlaxoSmithKline UK Ltd) 100 ml | |
| Augmentin 250/62 oral suspension (Sigma Pharmaceuticals Plc) 100 ml | |
| Co-amoxiclav 250mg/62mg/5ml oral suspension (A A H Pharmaceuticals Ltd) 100 ml | |
| Co-amoxiclav 250mg/62mg/5ml oral suspension (Alliance Healthcare (Distribution) Ltd) 100 ml | |
| Co-amoxiclav 250mg/62mg/5ml oral suspension (Almus Pharmaceuticals Ltd) 100 ml | |
| Co-amoxiclav 250mg/62mg/5ml oral suspension (Phoenix Healthcare Distribution Ltd) 100 ml | |
| Co-amoxiclav 250mg/62mg/5ml oral suspension (Sandoz Ltd) 100 ml | |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.